Eliyahu Sharon Kalif, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 111,550 shares at $17.08 ($1.9M) on 2025-06-12, disclosed to the SEC on 2025-06-16.
Scheduled sale ($1.9M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.08 | 55,775 | $953K | 50.0% |
| 2 | $17.08 | 55,775 | $953K | 50.0% |
| Total | $17.08 avg | 111,550 | $1.9M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-02 | $11.6M | — | Filing → |
| TEVA | SELL | 2025-03-04 | $1.8M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.0M | — | Filing → |